These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24510471)

  • 1. Memantine improves goal attainment and reduces caregiver burden in Parkinson's disease with dementia.
    Leroi I; Atkinson R; Overshott R
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):899-905. PubMed ID: 24510471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.
    Emre M; Tsolaki M; Bonuccelli U; Destée A; Tolosa E; Kutzelnigg A; Ceballos-Baumann A; Zdravkovic S; Bladström A; Jones R;
    Lancet Neurol; 2010 Oct; 9(10):969-77. PubMed ID: 20729148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.
    Larsson V; Engedal K; Aarsland D; Wattmo C; Minthon L; Londos E
    Dement Geriatr Cogn Disord; 2011; 32(4):227-34. PubMed ID: 22122992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
    Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
    Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies.
    Wesnes KA; Aarsland D; Ballard C; Londos E
    Int J Geriatr Psychiatry; 2015 Jan; 30(1):46-54. PubMed ID: 24737460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study.
    Stubendorff K; Larsson V; Ballard C; Minthon L; Aarsland D; Londos E
    BMJ Open; 2014 Jul; 4(7):e005158. PubMed ID: 24993765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment.
    Johansson C; Ballard C; Hansson O; Palmqvist S; Minthon L; Aarsland D; Londos E
    Int J Geriatr Psychiatry; 2011 Feb; 26(2):206-13. PubMed ID: 20665553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of memantine in dementia associated with Parkinson's disease.
    Leroi I; Overshott R; Byrne EJ; Daniel E; Burns A
    Mov Disord; 2009 Jun; 24(8):1217-21. PubMed ID: 19370737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Perstenev SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):37-42. PubMed ID: 19008850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.
    Vidal EI; Fukushima FB; Valle AP; Villas Boas PJ
    J Am Geriatr Soc; 2013 Jan; 61(1):170-2. PubMed ID: 23311565
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
    Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia.
    Larsson V; Aarsland D; Ballard C; Minthon L; Londos E
    Int J Geriatr Psychiatry; 2010 Oct; 25(10):1030-8. PubMed ID: 20872929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Caregiving Experience of Grief, Burden, and Quality of Life in Dementia with Lewy Bodies, Alzheimer's Disease, and Parkinson's Disease Dementia.
    Rigby T; Johnson DK; Taylor A; Galvin JE
    J Alzheimers Dis; 2021; 80(1):421-432. PubMed ID: 33554912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caregiver burden in Parkinson disease with dementia compared to Alzheimer disease in Korea.
    Shin H; Youn J; Kim JS; Lee JY; Cho JW
    J Geriatr Psychiatry Neurol; 2012 Dec; 25(4):222-6. PubMed ID: 23172764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia.
    Litvinenko IV; Odinak MM; Mogil'naya VI; Perstnev SV
    Neurosci Behav Physiol; 2010 Feb; 40(2):149-55. PubMed ID: 20033305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of a multimodal cognitive and physical rehabilitation program for persons with mild dementia and their caregivers: a goal-oriented approach.
    Chew J; Chong MS; Fong YL; Tay L
    Clin Interv Aging; 2015; 10():1687-94. PubMed ID: 26543358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Memantine can relieve certain symptoms in Parkinson disease. Improvement achieved in two out of three described cases with dyskinesia and cognitive failure].
    Lökk J
    Lakartidningen; 2004 Jun; 101(23):2003-6. PubMed ID: 15232837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of sleep quality on caregiver burden in Parkinson's disease.
    Bartolomei L; Pastore A; Meligrana L; Sanson E; Bonetto N; Minicuci GM; Marsala SZ; Mesiano T; Bragagnolo L; Antonini A
    Neurol Sci; 2018 May; 39(5):835-839. PubMed ID: 29445989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA antagonist memantine improves levodopa-induced dyskinesias and "on-off" phenomena in Parkinson's disease.
    Varanese S; Howard J; Di Rocco A
    Mov Disord; 2010 Mar; 25(4):508-10. PubMed ID: 20014061
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.